BIOVIA

BIOVIA is a software company headquartered in the United States, with representation in Europe and Asia. It provides software for chemical, materials and bioscience research for the pharmaceutical, biotechnology, consumer packaged goods, aerospace, energy and chemical industries.

Accelrys
Subsidiary
Traded asNASDAQ: ACCL
IndustryLife sciences, Materials science, CPG, Automotive, Aerospace, Energy, Academic, Manufacturing, Technology
Founded2001
HeadquartersSan Diego, California, United States
Cambridge, United Kingdom
Tokyo, Japan
Key people
Max Carnecchia (CEO)
Jason Gray, General Counsel
Matt Hahn, Senior Vice President and Chief Technology Officer
Leif Pedersen, Senior Vice President of Marketing, Product Management and Corporate Development
RevenueUS$155 million
Number of employees
700+
Websitewww.accelrys.com

Originally named Accelrys, it is a wholly owned subsidiary of Dassault Systèmes after an April 2014 acquisition[1] and has been renamed BIOVIA.[2]

History

Accelrys was formed in 2001 as a wholly owned subsidiary of Pharmacopeia, Inc.[3] from the fusion of five companies: Molecular Simulations Inc. (MSI, itself a result of the combination of Biodesign, Cambridge Molecular Design, Polygen and, later, Biocad and Biosym Technologies), Synopsys Scientific Systems, Oxford Molecular, the Genetics Computer Group (GCG), and Synomics Ltd.

In late 2003, Pharmacopeia, Inc. separated its drug discovery and software development businesses. The drug discovery company retained the name Pharmacopeia and remained in Princeton, New Jersey, with ~170 employees. The software company, with ~530 employees and 2002 revenue of $95.1 million would move to San Diego, California.[4]

In 2004, Accelrys acquired SciTegic, producer of the Pipeline pilot software.[5]

On Dec 22, 2005, Accelrys, Inc. announced to restate its historical financial statements, to reflect changes to the timing of revenue recognition on certain historical term-based contracts, substantially all of which were entered into prior to January 2004.[6]

Accelrys managed a nanotechnology consortium producing software tools for rational nanodesign from 2004 to 2010.[7]

In 2010, Symyx Technologies was merged with Accelrys.[8]

In May 2011, the company acquired Contur Software AB, an electronic lab notebook software firm.[9]

In January 2012, Accelrys acquired VelQuest, a maker of pharmaceutical and medical device-related software, for $35 million in cash.[10]

In May 2012, Accelrys purchased Hit Explorer Operating System (HEOS) - a SaaS system that provides groups with project information in the cloud and access to biological assay results, analytics, chemical registration and pharmacokinetics data - from Scynexis.[11]

In October 2012, Accelrys acquired Aegis Analytical Corp. for $30 million in cash, expanding Accelrys’ reach for customers in the move from the lab to the manufacturing floor.[12] The company’s Discoverant software aggregates and analyzes manufacturing, quality and development data to allow manufacturers for quality by design.[13]

In January 2013, Accelrys acquired Swiss biosciences systems integrator Vialis AG for $5 million in cash.[13]

In September 2013, Accelrys acquired Environmental Health & Safety (EH&S) compliance provider ChemSW.[14]

On January 30, 2014 Dassault Systèmes of France announced the acquisition of Accelrys in an all-cash tender offer for at $12.50 per share, representing a fully diluted equity value for Accelrys of approximately $750 million. After the acquisition Accelrys was renamed BIOVIA.[2]

Products
  • The Accelrys Enterprise Platform, a scientifically aware, service-oriented architecture (SOA) spanning data management and informatics, enterprise lab management, modeling and simulation, and workflow automation.[15]
  • Pipeline Pilot, a program that aggregates and provides immediate access to the volumes of disparate research data locked in silos, automates the scientific analysis of that data, and enables researchers to rapidly explore, visualize and report research results.
  • ISIS/Draw, a chemical drawing tool.
  • ISIS/Base, a personal chemical database counterpart.
  • ISIS/Host, a chemical structure database that uses Oracle
  • Accelrys Draw, a chemical drawing tool.
  • Accelrys Direct, a chemical substance database that uses Oracle's data cartridge technology.
  • The Available Chemicals Directory (ACD) a compilation of supplier catalogues that is searchable by substructure.
  • The Accelrys Process Management and Compliance Suite, a "combination of software products for scientists working in early and mid-stage analytical, formulation and process/bioprocess development ... through to stability, material and release testing during late-stage quality control and commercial production." The Suite streamlines product development [16]
  • Symyx Notebook by Accelrys, an Electronic lab notebook.
  • Materials Studio, a suite of modeling and simulation programs for material science.
  • Discovery Studio, a suite of modeling and simulation programs for life sciences.
  • Contur ELN
  • Externalized Collaboration Suite
  • Discoverant
  • iLabber
  • Experiment Knowledge Base
  • Lab Executive System (LES)

Commercial versions of otherwise academically licensed programs:

  • CHARMM (Chemistry at Harvard Macromolecular Mechanics) is commercially available from Accelrys. In October 2013, Martin Karplus of Harvard University, Michael Levitt of Stanford University and Arieh Warshel of the University of Southern California were awarded the 2013 Nobel Prize in chemistry for their work in modeling and simulation including CHARMM.[17]
  • MODELLER
gollark: ++fortune
gollark: Ohhh.
gollark: ++help
gollark: ++fortune
gollark: ++exec```hs(^∆) x y = 2 + x `div` y + (x * y * (-y))main = print $ 1 ^∆ 3```

See also

Other institutions developing software for computational chemistry:

References
  1. "Dassault Systèmes Successfully Completes Acquisition of Accelrys". marketwatch.com. 29 Apr 2014. Retrieved 28 May 2014.
  2. Quested, Tony (9 June 2014). "Accelrys rebrands after gamechanging acquisition". Business Weekly. Retrieved 29 February 2016.
  3. "SEC FORM 8-K". 29 Jun 2001. Retrieved 28 May 2014.
  4. "PHARMACOPEIA TO SPIN OFF DRUG-DISCOVERY BUSINESS". NYtimes.com. 19 Dec 2003. Retrieved 28 May 2014.
  5. Accelrys company information
  6. "Accelrys to Restate Financials".
  7. Nanotechnology Consortium Archived 2010-12-12 at the Wayback Machine. Accelrys.
  8. "Accelrys to merge with Symyx Technologies". San Diego Union-Tribune. Retrieved 2020-06-11.
  9. "Accelrys Acquires Contur Software for $13.1M". GenomeWeb. Retrieved 2020-06-11.
  10. "Accelrys Picks Up VelQuest with $35M to Bolster Informatics Offerings". Genengnews.com. Retrieved 2012-08-19.
  11. Ryan McBride (2012-05-21). "Accelrys snaps up discovery software from Scynexis". FierceBiotechIT. Retrieved 2012-08-19.
  12. "Archived copy". Archived from the original on 2014-05-29. Retrieved 2012-10-30.CS1 maint: archived copy as title (link)
  13. "Accelrys Inc. Acquires Vialis AG for $5M". SanDiegoBusJournal. 15 Jan 2013. Retrieved 29 May 2014.
  14. http://www.pharmamanufacturing.com/industrynews/2013/338/
  15. "Accelrys Announces Enterprise Platform". Sdcexec.com. 2012-04-20. Retrieved 2012-08-19.
  16. "Archived copy". Archived from the original on 2012-11-05. Retrieved 2012-09-20.CS1 maint: archived copy as title (link)
  17. http://www.rsc.org/chemistryworld/2013/10/chemistry-nobel-prize-2013
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.